OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
Emanuel Bührer, Michal Kiciński, Mario Mandalà, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 9, pp. 1202-1212
Closed Access | Times Cited: 5
Emanuel Bührer, Michal Kiciński, Mario Mandalà, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 9, pp. 1202-1212
Closed Access | Times Cited: 5
Showing 5 citing articles:
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
Alexander M.M. Eggermont, Michal Kiciński, Christian U. Blank, et al.
European Journal of Cancer (2024) Vol. 211, pp. 114327-114327
Closed Access | Times Cited: 21
Alexander M.M. Eggermont, Michal Kiciński, Christian U. Blank, et al.
European Journal of Cancer (2024) Vol. 211, pp. 114327-114327
Closed Access | Times Cited: 21
Real-World Impact of Low-Grade Toxicities to Adjuvant Pembrolizumab in Stage III Melanoma
Nasreen Abdul Aziz, David Burke, Sharanniyan Ragavan, et al.
JCO Oncology Practice (2025)
Closed Access
Nasreen Abdul Aziz, David Burke, Sharanniyan Ragavan, et al.
JCO Oncology Practice (2025)
Closed Access
Measuring success of adjuvant treatment for patients with melanoma
Brent O’Carrigan, Pippa Corrie
The Lancet Oncology (2024) Vol. 25, Iss. 9, pp. 1109-1110
Closed Access | Times Cited: 1
Brent O’Carrigan, Pippa Corrie
The Lancet Oncology (2024) Vol. 25, Iss. 9, pp. 1109-1110
Closed Access | Times Cited: 1
Capturing the true effect of anti-PD-1 therapy on patients’ health-related quality of life – Authors' reply
Emanuel Bührer, Michal Kiciński, Madeline Pe, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 12, pp. e618-e618
Closed Access
Emanuel Bührer, Michal Kiciński, Madeline Pe, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 12, pp. e618-e618
Closed Access
Capturing the true effect of anti-PD-1 therapy on patients’ health-related quality of life
Mees Egeler, Lonneke V. van de Poll‐Franse
The Lancet Oncology (2024) Vol. 25, Iss. 12, pp. e617-e617
Closed Access
Mees Egeler, Lonneke V. van de Poll‐Franse
The Lancet Oncology (2024) Vol. 25, Iss. 12, pp. e617-e617
Closed Access
